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Abstract  
Background: Acetaminophen is a common antipyretic drug but at overdose can cause severe hepatotoxicity that may 
further develop into liver failure and hepatic centrilobular necrosis in experimental animals and humans. This study 
was undertaken to assess the ameliorative role of Moringa peregrina leaves extract against acetaminophen toxicity in 
rats.  
Materials and methods: Induction of hepatotoxicity was done by chronic oral administration of acetaminophen (750 
mg/kg bwt) for 4 weeks. To study the possible hepatoprotective effect, Moringa peregrina leaves extract (200 mg/kg 
bwt) or Silymarin (50 mg/kg bwt) was administered orally, for 4 weeks, along with acetaminophen.  
Results: acetaminophen significantly increased serum liver enzymes and caused oxidative stress, evidenced by 
significantly increased tissue malondialdehyde, glutathione peroxidase, hepatic DNA fragmentation, and significant 
decrease of glutathione and antioxidant enzymes in liver, blood and brain.  On the other hand, administration of 
Moringa peregrina leaves extract reversed acetaminophen-related toxic effects through:  powerful malondialdehyde 
suppression, glutathione peroxidase normalization and stimulation of the cellular antioxidants synthesis represented by 
significant increase of glutathione, catalase and superoxide dismutase in liver, blood and brain, besides, DNA 
fragmentation was significantly decreased in the liver tissue.  
 Conclusion: acetaminophen induced oxidative damage can be improved by Moringa peregrina leaves extract-
treatment, due to its antioxidant potential. 
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Abbreviations:  ALP: Alkaline phosphatase, ALT: Alanine aminotransferase, APAP: Acetaminophen, AST: Aspartate 
aminotransferase, bp: base pair, bwt: body weight, CAT: Catalase, CYP450: cytochrome P450, DPPH: 1, 1-diphenyl-2-
picrylhydrazyl, FR: free radicals, GGT: Gamma glutamyl transferase, GPx: Glutathione peroxidase, GSH: Reduced 
glutathione, LPO: lipid peroxidation, MDA: Malondialdehyde, MPL: Moringa peregrinea leaves, P.o: per oral, SIL: 
Silymarin, SOD: Superoxide dismutase. 
 
 
Introduction 
 
Drug-induced liver injury has become a leading cause of severe liver disease in the world and is initiated by 
direct hepatotoxic effects of a drug, or a reactive metabolite of a drug (Russman et al., 2009). Acetaminophen (APAP), 
a widely used over-the-counter (OTC) analgesic and antipyretic, is one of the best known experimental models of 
hepatotoxicity (Lebda et al., 2013). It is safe in therapeutic doses, but causes fatal hepatic necrosis and hepatic failure in 
overdose (Bassems and vermeulen, 2001). 
 It was found that induction of cytochrome P450 (CYP450) isoforms (CYP2E1, CYP3A4, and CYP1A2), 
depletion of intracellular glutathione (GSH) and oxidative stress are the major mechanisms involved in the 
pathogenesis of APAP induced liver injury. These actions are mainly ascribed to the formation of 
N‐acetyl‐P‐benzoquinone imine (NAPQI), a highly toxic, reactive metabolite formed during cytochrome P450 
catalyzed oxidation of APAP (Bassems and vermeulen, 2001).  
Plants are a rich source of natural bioactive phytochemicals, such as antioxidants that can delay or inhibit the 
oxidation of lipids and other molecules, by inhibiting the initiation or propagation of oxidative chain reactions (Ali et 
al., 2011). The combination of medicinal plants with each others also may impact their medicinal values in some cases 
(Roy et al., 2012).  
Moringa peregrina (Forssk.) Fiori, [family: moringaceae] is a wild tree that grows in the eastern desert 
mountains in Egypt (Batanouny et al., 1999). Moringa peregrina leaves (MPL) extract was found to contain large 
number of phytoconstituents (El-Alfy et al., 2011). Scientifically, it has been proven that the leaves possess various 
pharmacologic effects, including hypoglycemic (El-Alfy et al., 2011), analgesic, anti-inflammatory and hypolipidimic 
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activities (El-Batran et al., 2005).  An in vitro study had demonstrated that MPL possessed antioxidant activity 
(Dehshahri et al., 2012). 
To our knowledge, no attempt has been made to study the hepatoprotective potential of MPL. Various reports 
had shown that antioxidant activity played significant role in the mechanisms of hepatoprotective activity (Muriel, 
2009).
 
Based on these data, the present study aimed to trace the antioxidant and hepatoprotective effects of the MPL 
extract on APAP induced chronic hepatotoxicity in rats in comparison with silymarin as a reference hepatoprotective 
agent. 
 
Methods 
Collection of plant material 
 
The fresh MPL were collected from Al-Orman garden, ministry of agriculture, Giza, Egypt. The plant 
specimen deposited in orman herbarium under code No. 64M. The plant was identified and authenticated by botanists 
in the orman herbarium in Al-Orman garden. A voucher specimen was kept in the herbarium of the Applied research 
center of medicinal plant No.3-6-2009, Moringa peregrine (Moringaceae). The leaves were dried under shade for 7 
days at room temperature, separated, and pulverized by mechanical grinder to form coarse powder. 
 
Preparation of Plant Extract 
 
The fresh dried powdered MPL was subjected to 70% ethanol extraction whereby 1 kg of powder leaves was 
macerated in 20 L of ethanol in the ratio of 1: 20 (w/v) for 72 hours. The supernatant was filtered sequentially using 
cloth filter, cotton wool, and Whatman filter paper number 1. The solvent was then evaporated under reduced pressure 
(204 mbar) and controlled temperature (40°C) using a vacuum rotary evaporator (Buchi Rotavapor R205, Switzerland). 
The whole processes were repeated twice for the remaining residue and then lyophilized using (lyophilizer.UM5sm, 
Nederland) to obtain powdered extract ( Mahmood et al., 2014).  
 
High-performance liquid chromatography (HPLC)-Assay of Flavonoids and phenolic compounds in MPL 
extract 
 
Flavonoid and phenolic compounds were HPLC-assayed according to the method of Mattila et al. (2000), 
using HPLC Agilent (series 1200) equipped with autosampling injector, solvent degasser, ultraviolet (UV) detector set 
at 330 nm and 280 nm for flavonoids and phenolic acids, respectively, and quarter HP pump (series 1050). The column 
temperature was maintained at 35°C. Separation was carried out with methanol and acetonitrile (2:1) as a mobile phase 
at a flow rate of 1ml/min. Flavonoids and phenolic compounds standards (Sigma Co.) were dissolved in the mobile 
phase and injected into HPLC. Retention time and peak area were used to calculate flavonoids and phenolic compounds 
concentration through data analysis of HEWLLET Packard software. 
 
1,1Diphenyl -2-picrylhydrazel free radical scavenging activity (DPPH assay). 
 
The antioxidant activity of MPL extract was determined according to the procedure described by Blois (2002), 
through preparing DPPH solution (0.3 mM in methanol), serial concentrations of MPL extract (5-250 µg/ml in 
methanol), and a standard ascorbic acid solution, as a positive control. Extracts (2.5 mL) were, then, mixed with DPPH 
(1.0 mL) and left in dark for 30 minutes, allowing the reaction to take place. The decrease in absorbance of the 
resulting solution was monitored at 517 nm.  
 
Animals 
 
Sixty adult female albino rats weighing 160 ± 10 g were used. Animals were provided from the animal house 
of National Organization for Drug Control and Research (NODCAR) Giza, Egypt. They were housed in cages at room 
temperature of 25°C ±1 with a 12 hr light- dark cycle. Animals fed on standard rat chow diet and water ad libitium and 
acclimatized to the environment for a week prior to the experiment. Experiment was carried out in accordance with the 
protocols approved by the local experimental ethics committee.  
 
Experimental design 
 
Experiment lasted for 4 weeks. A total of 60 rats were divided randomly into 5 groups (12 rats each) as 
follows: 
Group1 (N): negative control, received water. Group2 (APAP): positive control, received APAP (750 mg/kg bwt). 
Group3 (MPL+APAP): received MPL extract (200mg/kg bwt) along with APAP (750 mg/kg bwt). Group4 
(SIL+APAP): received Silymarin (SIL) (50mg/kg bwt) along with APAP (750 mg/kg bwt). Group5 
(MPL+SIL+APAP): received MPL extract (200mg/kg bwt) and SIL (50mg/kg bwt) along with APAP (750 mg/kg 
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bwt). In the present study, the choice of the MPL extract dose, 200 mg/kg, was based on a previous report of the acute 
toxicity study (El-batran et al., 2005).  
The animals were fasted for 24 hours prior to the experiment under standard laboratory conditions, but, 
allowed to freely access distilled water (dH2O) ad libitum. After 24 hours, each group received the respective dose of 
test solution orally once daily for 28 consecutive days. The APAP was orally administered one hour after the extract 
administration. The biochemical parameters were determined 24 hours after the last dose. 
 
Preparation of blood Samples 
 
At the end of the experiment, all animals from each group were fasted overnight and blood samples were 
withdrawn from retro-orbital plexus vein of each rat according to the procedure described by Schermer (1967). 0.2 ml 
whole blood was added to 1.8 ml distilled water for determination of reduced glutathione (GSH). 0.1 ml of blood was 
haemolysed in 250 ml distilled water for estimation of catalase (CAT). The rest of the blood samples were centrifuged 
at 3000 rpm for 15 minutes.  
After centrifugation, the supernatant was separated and plasma samples were kept at -20°C until used for 
measuring the activities of ALT, AST, ALP, GGT, total protein, albumin and TBARS. Whereas, the red cells, in the 
residue, were washed twice with cold saline, then, 1ml of bi-distilled water was added and the erythrocytes were re-
suspended by agitation and lysed for 2 hours at 4C. 0.8 ml chloroform/ethanol mixture (3:5 v/v) and 0.3 ml of bi-
distilled water were added to 1.8 ml of homolysate to precipitate and centrifuged at 3000 rpm for 10 min. The 
chloroform/ethanol supernatant was used for superoxide dismutase (SOD) estimation. 
 
Preparation of liver and brain samples 
 
The rats were sacrificed by cervical dislocation and the livers and brains were rapidly removed. Liver and 
brain were divided into four parts. The first part: was homogenized in phosphate buffer, pH 7.4, at a concentration of 
1:10 w/v, using homogenizer (stuart-SHM2-U.K). The homogenate was then centrifuged at 3000 r.p.m for 10 minutes, 
and the supernatant obtained was used for the determination of hepatic CAT and glutathione peroxidase (GSHPX) in 
liver and brain. The second part: was homogenized in cold 5% sulfosalicylic acid solution (1:20 w/v) then centrifuged 
at 3000 r.p.m. for 10 minutes, and the supernatant was used for estimating liver and brain glutathione. The third part: 
was homogenized in ice-cold tris HCl buffer (0.01M), pH 7.5, centrifuged at 15000 r.p.m. for 15 minutes, and the 
supernatant was used for measuring liver and brain superoxide dismutase.The fourth part: was homogenized in cold 
KCl (1.15 %) to make a 10% homogenate, centrifuged at 3000 r.p.m. for 10 minutes, and the supernatant was used for 
measuring liver and brain malondialdehyde (MDA). 
 
Biochemical blood analysis 
 
Hepatic injury was assessed through measuring plasma levels of ALT, AST (Retiman et al., 1957), ALP 
(Belfield et al., 1971), GGT (Szasz, 1969), total protein (TP) (Tietz, 1994) and Albumin (Doumas et al., 1971). The 
aforementioned parameters were determined spectrophotometrically using commercial kits (Biodiagnostic co., Egypt) 
and UV- visible spectrophotometer (thermo. Nicolet evolution100- England). 
 
 
 
Estimation of biomarkers of lipid peroxidation, oxidative stress and antioxidant enzymes in plasma and 
erythrocytes 
 
Plasma lipid peroxidation level was measured as the concentration of MDA, using the method described by 
Buege and Aust (1978). Whereas, GSH concentration, Cu/Zn-SOD and CAT activities were determined in erythrocytes 
using the methods of Beutler et al. (1963), Marklund and Marklund (1974) and Aebi (1984), respectively. 
 
 
Estimation of oxidative stress biomarkers in liver and brain 
 
Liver and brain tissue homogenates were used for spectrophotometric determination of the following 
parameters: 1) MDA level, as an index of lipid peroxidation, was measured according to the colorimetric method of 
Uchiyama and Mihara (1978). 2) GSH concentration was measured according to Beutler et al. (1963). 3) The activities 
of SOD and 4) CAT were determined using kinetic colorimetric methods of Marklund and Marklund (1974) and Aebi 
(1984), respectively. 5) Glutathione peroxidase (GPx) activity was measured using the method described by Rotruck et 
al. (1973). 6) Total protein, needed for tissue parameters calculation, was determined through the method of Lowry et 
al. (1951). 
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Analysis of total genomic DNA, using DNA fragmentation assay 
  
DNA fragmentation assay was performed using the salting out extraction technique (Aljanabi and Martinez, 
1997), followed by agarose gel electrophoresis (Hassab El-Nabi, 2004). The DNA bands intensities were assessed 
using Biogene software (Biogene software, France. 
 
 
Statistical analysis 
 
Results of biochemical assays were presented as mean ± S.E. and analysed statistically using one-way analysis 
of variance (SPSS 17.0) according to Snedecor and Cochran (1981), followed by Tukey’s post-hoc test for multiple 
comparisons. Results were considered to be significantly different when p < 0.05.  
 
 
Results 
HPLC-Assay of Flavonoids and phenolic compounds in MPL extract 
 
As presented in Table 1 and Fig 1, the flavonoids identified in MPL that showed the highest concentrations 
were rutin: 487.3 mg/100 g dry extract, naringin: 45.4 mg/100 g dry extract and quercetin: 14.32 mg/100 g dry extract, 
while, the lowest flavonoid concentration identified in MPL, was that of 7-OH flavone: 0.31 mg/100 g dry extract. 
Whereas, Table 2 and Fig 1 show that the highest concentrations of phenolic compounds identified in MPL, 
were those of 3-OH-tyrosol: 1763.7, protocatechein: 444.4 and epicatechein: 413.1 (mg/ 100 g dry extract). Table 2 and 
Fig 1 also reveal that the lowest phenolic compound concentration identified in MLE was that of P-coumaric acid: 1.96 
mg/100 g dry extract 
 
 
Figure 1: High- performance liquid chromatography (HPLC) chromatograms of MPL, at 280 nm (A) and 330 nm (B).   
 
Table 1: Concentrations of Flavonoids in MPL extract. 
Flavonoids Concentration (mg/100g) Flavonoids Concentration (mg/100g) 
Vitexin 16.52 Narengenin 1.1 
Naringin 45.43 Kampferol 1.82 
Rutin 487.3 Hisperetin 2.27 
Rosmarinic 3.67 Apegenin 5.43 
Quercetrin 6.96 7-OH flavone 0.31 
Quercetin 14.32   
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Table 2: Concentrations of phenolic compounds in MPL extract: 
 
Phenolic compound Concentration  
(mg/100g) 
Phenolic compound Concentration 
(mg/100g) 
Gallic 15.1 Chicoric 96.9 
Pyrogallol 243.14 Ferulic 52.1 
3-OH-Tyrosol 1763.74 Iso-ferulic 29.8 
4-Amino-benzoic 23.1 e-vanillic 485.25 
Protochatcuic 444.43 Reversetrol 19.5 
Chlorogenic 93.42 Ellagic 60.82 
Catechol 165.65 Alpha-coumaric 12.1 
Epichatichein 413.1 Benzoic 71.57 
Salyclic 157.65 3,4,5-methoxy-cinnamic 10.5 
Caffeine 64.33 Coumarin 8.24 
P-OH-benzoic 51.72 P-coumaric 1.96 
Caffeic 51.44 Cinnamic 6.02 
Vanillic 49.22   
 
DPPH assay: 
 
Scavenging of DPPH represents the free radicals reducing activity of antioxidants based on a one-electron 
reduction which was determined by the decrease of its absorbance at 520 nm. MPL extract exhibited significant 
antioxidant activity in the DPPH assay in a concentration-dependent manner. The leaf extract showed IC50 value of 7.1 
± 0.31 µg/ml compared with ascorbic acid, which was used as the positive control with IC50 value of 4.6 ± 0.22 μg/ml 
(Fig. 2).  
 
 
Figure 2: Percentage of DPPH inhibition against different concentrations of MPL extract and Ascorbic acid. Values 
are mean ± standard error of triplicate determinations. 
 
Effects of MPL Extract on serum hepatic marker enzymes 
  
The activities of serum hepatic marker enzymes, ALT, AST, ALP and GGT were significantly elevated in 
APAP treated rats, compared to normal rats. (Table 3). The decrease in total protein and albumin were non-significant 
when compared to N group. Meanwhile, oral administration of MPL, SIL and MPL+SIL together with APAP 
significantly decreased the increased activities of serum hepatic marker enzymes in comparison with the normal 
control group, where treatment with the mixture (MPL+ SIL) showed no more pronounced effects, compared to the 
groups administered one extract only with APAP. 
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Table 3: Effects of MPL and SIL on hepatic ALT, AST, ALP and GGT levels in APAP induced hepatotoxicity in 
experimental rats.  
 
                      Groups 
 Parameter 
N APAP MPL+ APAP  SIL+ APAP MPL+SIL+APAP 
ALT (U/L) 25.3  1.1(b) 71.8  2.7(a) 37.8  1.3(ab) 33.3  1.7(ab) 30.8  1.2(b) 
AST (U/L) 67.6  3.2(b) 128  6.4(a) 73.6  3.0(b) 72.8  3.8(b) 71.3  2.7(b) 
ALP (U/L) 117.7 ± 5.1
(b)
 156.5 ± 1.8
(a)
 127.4 ± 3.8
(a)
 123.6 ± 5.3
(b)
 120.2 ± 4.9
(b)
 
GGT (U/L) 8.3  0.33(b) 12.8 ± 0.83
(a)
 6.7 ± 0.33
(b)
 7.7 ± 0.33
(b)
 7.2 ± 0.26
(b)
 
TP(mg/dl) 8.1  0.4 6.5  0.32 7.9  0.56 7.8  0.32 8.2  0.56 
Albumin(mg/dl) 3.6  0.16 3.3  0.16 3.5  0.16 3.3  0.19 3.2  0.22 
Values are expressed as means ±SEM of 12 rats per group; p<0.05 (using one-way ANOVA followed by Tuckey’s 
HSD post-hoc test); 
a
significant difference from normal control group; 
b
significant difference from APAP treated 
group.  
 
Effect of MPL Extract on Oxidative Stress Markers in APAP Induced Toxicity  
 
Tables 4- 6 showed that APAP intoxication resulted in a state of oxidative stress in the liver, revealed by the 
results of the biochemical tests. Administration of APAP to experimental animals caused an increase in lipid 
peroxidation, and hence, in MDA production in blood, liver and brain compared to the negative control group. Groups 
treated with either MPL or SIL showed significant reduction of the elevated MDA levels. On the contrary, reduced 
glutathione (GSH), was severely diminished in liver, brain and blood of animals given APAP. Administration of MPL 
extract or SIL, either alone or in combination, along with APAP, succeeded in replenishing GSH stores in blood, liver 
and brain. Meanwhile, the activities of SOD, CAT and GPx were significantly lowered in APAP intoxicated rats. After 
administration of MPL extract or SIL, there was a powerful enhancement in the activities of CAT and SOD, as well as 
a complete normalization in GPx activity. 
 
Table 4: Effect of MPL and SIL on blood GSH, CAT, SOD and MDA in APAP induced hepatotoxicity in 
experimental rats.  
 
             Group 
Parameters 
N APAP MPL+ APAP  SIL+ APAP MPL+SIL+APAP 
GSH (mg/dl) 40.4  2.80(b) 30.8  1.65(a) 42.9  1.02(b) 42.6  1.39(b) 44.5 ± 2.35
(b)
 
CAT (U/ml) 97.3  5.6(b) 69.9  4.2(a) 97.98  6.5(b) 102.7  4.8(b) 93.8  3.2(b) 
SOD (U/mg Hb) 23.7  1.1(b) 14.0   1.2(a) 22.8  0.9(b) 23.5  0.9(b) 25.1   1.6(b) 
MDA (nM/ml) 8.64  0.42(b) 13.34  0.79(a) 9.83  0.69(b) 10. 56  0.56(b) 9.24   0.27(b) 
Values are expressed as means ±SEM of 12 rats per group; p<0.05 (using one-way ANOVA followed by Tuckey’s 
HSD post-hoc test); 
a
significant difference from normal control group; 
b
significant difference from APAP treated 
group. 
 
Table 5: Effect of MPL and SIL on hepatic GSH, CAT, SOD, MDA and GPx in APAP induced hepatotoxicity in 
experimental rats.   
                    Groups 
 Parameter 
N APAP MPL + APAP  SIL+ APAP MPL+SIL+APAP 
GSH (µg/mg pt) 29.88  1.71(b) 13.96  0.98(a) 28.87  1.75(b) 27.29  2.17(b) 30.0  2.34 (b) 
CAT (U/ mg pt) 64.7  1.92(b) 38.3  1.35(a) 59.5  2.98(b) 58.7  2.68(b) 60.9  2.11(b) 
SOD (U/ mg pt) 14.54  0.68(b) 6.40  0.45(a) 14.10  0.63(b) 13.22  0.78(b) 14.2  0.59(b) 
MDA (nM / mg pt) 1.35  0.11(b) 2.71  0.17(a) 1.40  0.07(b) 1.51  0.09(b) 1.43  0.08(b) 
GPx(g of 
glutathione 
utilized/min/mg pt) 
21.9  1.12(b) 29.5  1.91 (a) 23.6  1.0(b) 22.9  1.32(b) 21.2  1.21(b) 
Values are expressed as means ±SEM of 12 rats per group; p<0.05 (using one-way ANOVA followed by Tuckey’s 
HSD post-hoc test); 
a
significant difference from normal control group; 
b
significant difference from APAP treated 
group. 
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Table 6: Effect of MPL and SIL on brain GSH, SOD, MDA and GPx in APAP induced hepatotoxicity in experimental 
rats.   
                     Groups 
 Parameter 
N APAP MPL+ APAP  SIL+ APAP MPL+SIL+APAP 
GSH (µg/mg pt) 6.45  0.44(b) 3.72  0.16(a) 6.36  0.21(b) 6.10  0.45(b) 6.87  0.22(b) 
SOD (U/ mg pt) 5.2  0.4 3.8  0.2 5.9  0.4(b) 5.4  0.5 6.1  0.5(b) 
MDA (nM / mg pt) 1.38 ± 0.05
(b)
 2.07 ± 0.10
(a)
 1.60 ± 0.04
(b)
 1.65 ± 0.06
(b)
 1.50 ± 0.03
(b)
 
GPx(g of 
glutathione 
utilized/min/mg pt) 
5.77  0.49(b) 7.94  0.69(a) 6.78  0.27 6.90  0.35 6.51  0.30 
Values are expressed as means ±SEM of 12 rats per group; p<0.05 (using one-way ANOVA followed by Tuckey’s 
HSD post-hoc test); 
a
significant difference from normal control group; 
b
significant difference from APAP treated 
group. 
 
Analysis of total genomic DNA  
Analysis of total genomic DNA, using DNA fragmentation assay   
 
Table (7) and Fig 3 and 4 show the effects of different treatments on the total genomic DNA damage induced 
by APAP in albino rats’ liver, after 4 wks of treatment. Where, severe damage was observed in the DNA of the APAP 
treated rats livers, appeared in the second lane, L2, As indicated, the massive DNA release in L2 was followed by 
migration in the form of smear shape indicating necrosis.  
This pattern of migration of the released DNA (necrosis) disappeared in all the lanes representing the other 
treatments, L3: APAP+MPL; L4: APAP+SIL; L5: and APAP+SIL+MPL, indicating the presence of protective effects, 
attributed to these treatments.   
The power of protection against DNA damage was in the following descending order: L3 L5 L4. Where, 
only a small portion of the DNA in L3 was released and migrated only to 2000 bps, showing the highest level of 
protection for MPL treatment amongst the other treatments. In L5, less protection was shown by mixture treatment, 
where, most of the DNA remained intact at 4000 bps, however the remaining little portion was fragmented into a few 
apoptotic bands at 2000, 1000 and 800. Whereas, silymarin treatment exerted the least level of protection, where, it 
only protected a smaller portion of DNA, from being released and migrated into several apoptotic bands, at 2000, 1000, 
800 and 600 bps. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Digital photograph of DNA electrophoresis of liver tissues shows the protective effects of different 
treatments against APAP toxicity, where, L1: negative control (N); L2: APAP; L3: APAP+MPL; L4: APAP+SIL; L5: 
APAP+SIL+MPL and M: DNA marker. 
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Figure 4: The analytical peaks for DNA lanes which resemble the same lanes in Fig. 2 using Biogene software.  
 
Table (7): Protective effect of different treatments on total genomic DNA damage in albino rats 
 
Discussion 
 
The present study examined the in vitro antioxidant potential of MPL extract, using DPPH assay. It aimed, 
also, to point out the in vivo antioxidant and free radical scavenging activities of MPL against APAP toxicity in rats.  
The obtained results of DPPH assay revealed that MPL extract possesses a high free radical scavenging activity 
compared to vitamin C. The antioxidant potential of MPL extract can be attributed to the presence of considerable 
amounts of phenolic compounds and flavonoids, identified in the extract. Where, phenolics, generally, act as free 
radical scavengers (Dai J and Mumper, 2010) and flavonoids have been reported to exert antioxidant, anti-
inflammatory and hepatoprotective activities (Mahmood et al., 2014).   
In the present study, the deleterious effect of the toxic APAP dose on liver function is emphasized by 
significant elevation in plasma AST, ALT, ALP and GGT activities in APAP rats, as compared to N group. The 
activities of ALT, AST, ALP and GGT used as biochemical markers for evaluation of early hepatic injury. 
These enzymes are normally located in the cytoplasm, mitochondria or microsomes. Consequently, these 
enzymes are released into the circulation after cellular leakage and loss of functional integrity of cell membrane, in 
liver, due to this hepatotoxicity (Lahkar and Thakuria, 2012). Furthermore, alterations in the permeability of cell 
membrane, increased synthesis or decreased catabolism of aminotransferases may explain this elevation (Nuduka, 
1999). A possible explanation by which serum ALP level was elevated may be related to the increase in its synthesis by 
cells lining bile canaliculi in response to cholestasis and increased biliary pressure. The aforementioned increase of 
liver parameters in APAP-rats is also supported by preceding studies that agreed with our consequences (Lebda et al., 
2013).  
Based on all of the abovementioned outcomes, our experiment provided an evidence for the hepatoprotective 
effect of MPL, as revealed by its potential in significantly attenuating the increased activities of serum hepatic 
enzymes, after administration of MPL, alone or in combination with silymarin, in comparison with APAP group. The 
decreased enzymes level, after treatment with MPL, SIL or mixture of both, indicates that these treatments might 
preserve the structural integrity of the hepatocellular membrane against APAP.  
Despite the insignificant effect of APAP on total protein and albumin in the present study, there are conflicting 
results reported by Lotkova et al. (2009) who demonstrated a significant decrease in albumin synthesis by 30% in 
APAP treated group in comparison with controls. 
The observations of the current study clearly demonstrated that, at the end of the experimental period, APAP 
overdose induced imbalance between ROS production and antioxidant defense which resulted into oxidative stress in 
Groups N APAP MPL+APAP SIL+ APAP MPL+SIL+APAP 
Intact DNA (4000 bp) 2900 2180 5065 1820 4160 
2000 bp - - 902 3405 1265 
1000 bp - - - 400 950 
800 bp - - - 1750 1050 
600 bp - 6830 - 870 - 
Azim et al., Afr J Tradit Complement Altern Med., (2017) 14 (2): 206-216 
doi:10.21010/ajtcam.v14i2.22 
214 
 
the liver and lipid peroxidation (LPO) as shown by the increased MDA content and GPx enzyme activity, and the 
decrease in GSH, SOD and CAT in liver, blood and brain.  
Previous mechanistic studies indicated that the metabolic activation of APAP to the reactive metabolite NAPQI 
(Lu, 2009), which can directly react with GSH a non-enzymatic antioxidant thiol, exhibits dramatic depletion of 
cellular content of GSH. At APAP overdose, significant decrease in GSH causes the endogenous reactive oxygen 
species to bind to cellular macromolecules leading to initiation of LPO processes, membrane breakdown, and cell death 
indicating that oxidative stress has a prime role in the mechanism of APAP toxicity (Mohammed and Safwat, 2013). 
Likely, SOD is known to be the primary defense system against oxidative stress. CAT is one of the most important 
intracellular enzymes in the detoxification of the oxidant hydrogen peroxide. The reduction in the activities of CAT and 
SOD enzymes in APAP rats was attributed to the increased utilization of these enzymes in scavenging and neutralizing 
the free radicals and lipid peroxides (Singh et al., 2011). The aforementioned data are in harmony with those obtained 
by El-Banna et al. (2013) and Soares et al. (2013). 
According to the current results, administration of MPL, solely or combined with silymarin, maintained the 
activities of antioxidant enzymes within normal levels and increased level of reduced glutathione. These actions are 
mainly ascribed to the high content of phenolic compounds and flavonoids (rutin, quercetin and naringin), present in 
MPL, which possess antioxidant abilities (El-Alfy et al., 2011). Flavonoids has been proposed to exert antioxidant 
effects through enhancement of endogenous antioxidant SOD and CAT (Cetin et al., 2008). Additionally, quercetin has 
been reported to inhibit cytochrome P450 enzymes so decreases the formation of toxic reactive metabolite NAPQI 
(Sandhar et al., 2011). Moreover, quercetin mediates induction of GSH synthesis through activation of gene expression 
of most of the key proteins implicated in the GSH synthesis (Nájera et al., 2013). These results showed that MPL 
extract was able to preserve the amount of GSH, which is important to counteract the APAP toxic effects 
In the present study, another evidence for the implication of APAP in the induction of oxidative stress was 
emerged by the elevation in MDA level, a toxic product of lipid peroxidation. It has been proven that hydrogen 
peroxide and superoxide anion are generated during biotransformation of APAP in the CYP450 system and from 
mitochondria during APAP intoxication (Hinson et al., 2002). The MPL extract was able to maintain normal levels of 
lipid peroxidation (MDA) in blood and both tissues. The phenomenon can, in principle at least, be attributed to the free-
radical scavenging ability of the MPL extract. Also it has been shown that apigenin and rutin inhibit many enzymes 
including, cyclooxygenase, lipooxygenase, and phospholipase which play significant role in generation of ROS (Tunon 
et al., 2009). 
Furthermore, our investigation demonstrated that GPx was significantly increased in APAP group. On one 
hand, there is accumulating evidence in harmony with our data, established by Soares et al. (2013) and Shull et al. 
(1991), who postulated that exposure of the epithelial cells to H2O2 causes a significant induction in mRNA of GPx, 
while, insufficient amounts of intracellular GSH, substrate of GPx, might explain why the level of lipid peroxidation in 
the liver was not affected by GPx overexpression, as well (Lubos et al., 2011). 
On the other hand, there are conflicting results concerning this theory reported by lebda et al. (2013) who 
demonstrated that APAP administration was accompanied by reduced GPx activity. Their hypothesis was that GPx 
could be consumed during the process of protection against chemically-induced oxidative destruction of lipids and 
proteins.  
In the current study, the DNA analysis, through gel electrophoresis, showed severe DNA damage to the liver 
tissues of APAP overdose treated rats; this result is in accordance with that of Gujral et al. (2002). The DNA damage 
observed in this study might be due to the oxidative stress state. Oxidative stress is known to cause severe DNA 
damage to various tissues. 
In this study, administration of MPL, silymarin or mixture significantly reduced the liver DNA damage. This 
protective effect against DNA damage was almost attributed to the antioxidant effects of these treatments. 
Finally, in the current study, the use of a mixture of MPL and silymarin was to detect whether it would have a 
synergistic effect as a hepatoprotective agent. However, we reported a synergistic effect for this mixture only in case of 
increasing the decreased GSH and SOD levels, and in case of decreasing the increased ALT and ALP levels in APAP 
treated rats. This weak synergism that has been shown to the mixture might be due to the similarity of the active 
constituents present in both MPL and silymarin, to which antioxidant and hepatoprotective effects are attributed. It 
worth nothing saying that similarity in structure gives similarity in activity. Furthermore, there was no summative 
effect in most of the parameters, and this was consistent with the preliminary studies, preceding this study, where we 
used a high dose of MPL comparing it to a low dose. Both doses gave nearly the same effect with no significant 
difference. This result encouraged the use of the low dose in the present study.  
In conclusion, the present data highlights that MPL is considered to be one of the antioxidants-rich plants 
which had a significant ameliorative effect on liver function and oxidative stress biomarkers in comparison with 
silymarin as a reference agent in APAP-induced hepatotoxicity in rats.  
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